cognitive cybersecurity intelligence

News and Analysis

Search

Paxlovid effective in reducing risk of long COVID symptoms: study

A recent preprint study found that Pfizer’s COVID-19 antiviral Paxlovid may be effective in reducing the risk of developing long COVID in patients recovering from coronavirus infections.

The study, funded by the Department of Veterans Affairs (VA), looked through the VA’s health care…

Source: thehill.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts